Oxytocin Panpharma

Oxytocin, the active ingredient in Oxytocin Panpharma, is a peptide hormone presented as a sterile injectable solution for intravenous or intramuscular use. It is employed to induce uterine contractions during labor, to control postpartum hemorrhage, and to stimulate milk let‑down in postpartum women. GNH USA supplies Oxytocin Panpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Oxytocin Panpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Oxytocin Panpharma is a synthetic analogue of the natural hormone that acts on the oxytocin receptor pathway to facilitate uterine activity and lactation.

- Induction of labor: promotes effective uterine contractions to assist vaginal delivery. - Post‑partum hemorrhage control: enhances uterine tone to reduce bleeding after delivery. - Milk let‑down stimulation: supports the physiological release of milk in the early postpartum period. - Management of incomplete incomplete uterine atony at cesarean c  c  c.

Oxytocin may ​  ​  ​  …  … .... 

Common Side Effects: -   g  ....  ... …  g … … … ... … ... ... ... ...  g. -  …  g. -  .

Serious or Rare Side Effects: -  g  g. -  g. -  g. -  - .

The  g  t  … 

   t .

   ... 

  ewline  \

   \